Travere Therapeutics (TVTX) Institutional Ownership $44.43 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$44.44 +0.01 (+0.01%) As of 05/22/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Travere Therapeutics (NASDAQ:TVTX)Number ofInstitutional Buyers(last 12 months)172TotalInstitutional Inflows(last 12 months)$560.91MNumber ofInstitutional Sellers(last 12 months)103TotalInstitutional Outflows(last 12 months)$1.11B Get TVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Travere Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TVTX Institutional Buying and Selling by Quarter Travere Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE1,345,111$39.96M0.0%-27.8%1.447% 5/18/2026 California State Teachers Retirement System105,132$3.12M0.0%+32.3%0.113% 5/18/2026 Rock Springs Capital Management LP1,477,954$43.91M2.6%-33.1%1.589% 5/18/2026 Elmind Capital LP177,600$5.28M1.5%+61.5%0.191% 5/18/2026 Empowered Funds LLC84,820$2.52M0.0%+2,719.8%0.091% 5/18/2026 Eversept Partners LP542,610$16.12M0.9%-53.8%0.584% 5/16/2026 Quantinno Capital Management LP68,317$2.03M0.0%+354.4%0.073% 5/15/2026 Rice Hall James & Associates LLC92,757$2.76M0.2%+1.3%0.100% 5/15/2026 Affinity Asset Advisors LLC300,000$8.91M0.5%-95.9%0.323% 5/15/2026 Entropy Technologies LP23,464$697K0.0%+5.7%0.025% Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2026 Renaissance Technologies LLC1,966,779$58.43M0.1%-12.5%2.115% 5/14/2026 Knott David M Jr140,633$4.18M2.5%-24.4%0.151% 5/14/2026 Sei Investments Co.166,477$4.95M0.0%+24.6%0.179% 5/13/2026 Militia Capital Management LLC29,700$882K0.2%N/A0.032% 5/13/2026 First Trust Advisors LP268,549$7.98M0.0%-21.4%0.289% 5/7/2026 Parallel Advisors LLC2,707$80K0.0%-28.5%0.003% 5/7/2026 KBC Group NV2,843$84K0.0%-32.1%0.003% 5/7/2026 Swiss National Bank168,100$4.99M0.0%+0.6%0.181% 5/6/2026 Assetmark Inc.19,636$583K0.0%-9.0%0.021% 5/5/2026 Bank of New York Mellon Corp217,226$6.45M0.0%-1.3%0.235% 5/5/2026 Hillsdale Investment Management Inc.182,320$5.42M0.1%+2.9%0.197% 5/4/2026 Calamos Advisors LLC54,245$1.61M0.0%-25.0%0.059% 5/4/2026 Emerald Mutual Fund Advisers Trust945,033$28.08M1.4%-0.4%1.023% 5/4/2026 Emerald Advisers LLC1,557,196$46.26M1.5%-2.3%1.686% 5/1/2026 Fifth Third Bancorp1,191$35K0.0%N/A0.001% 5/1/2026 Candriam S.C.A.369,995$10.99M0.1%-21.0%0.401% 4/30/2026 Hsbc Holdings PLC396,853$11.79M0.0%N/A0.430% 4/30/2026 First Horizon Corp2,942$87K0.0%-9.1%0.003% 4/29/2026 Burney Co.39,724$1.18M0.0%N/A0.043% 4/28/2026 Stephens Investment Management Group LLC1,798,466$53.43M0.7%+4.5%1.947% 4/27/2026 Private Advisor Group LLC15,422$458K0.0%+24.3%0.017% 4/27/2026 Y Intercept Hong Kong Ltd117,361$3.49M0.1%+196.6%0.127% 4/22/2026 Pictet Asset Management Holding SA529,757$14.68M0.0%-0.9%0.574% 4/20/2026 Assenagon Asset Management S.A.7,927$236K0.0%-98.1%0.009% 4/16/2026 SG Americas Securities LLC54,691$1.63M0.0%+60.4%0.059% 4/16/2026 Diversified Trust Co28,161$837K0.0%+12.4%0.030% 3/17/2026 Rockefeller Capital Management L.P.2,642$101K0.0%+1,604.5%0.003% 2/19/2026 Invesco Ltd.474,075$18.11M0.0%-24.5%0.530% 2/18/2026 Mercer Global Advisors Inc. ADV7,272$278K0.0%N/A0.008% 2/18/2026 Mackenzie Financial Corp41,390$1.56M0.0%-17.8%0.046% Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock free2/18/2026 Empowered Funds LLC3,008$115K0.0%N/A0.003% 2/18/2026 KVP Capital Advisors LP91,000$3.48M3.4%N/A0.102% 2/18/2026 XTX Topco Ltd60,680$2.32M0.1%+475.0%0.068% 2/18/2026 VARCOV Co.6,814$260K0.1%N/A0.008% 2/18/2026 Voloridge Investment Management LLC867,622$33.15M0.1%-1.8%0.970% 2/18/2026 Virtus Investment Advisers LLC19,620$750K0.2%-34.0%0.022% 2/18/2026 Wellington Management Group LLP798,984$30.53M0.0%-33.5%0.893% 2/18/2026 Tudor Investment Corp ET AL62,186$2.38M0.0%-35.1%0.070% 2/18/2026 Superstring Capital Management LP38,022$1.45M0.8%-29.1%0.042% 2/18/2026 Perceptive Advisors LLC4,278,180$163.47M2.9%+12.7%4.782% 2/18/2026 Janus Henderson Group PLC10,511,166$401.72M0.2%-38.0%11.748% 2/18/2026 Gotham Asset Management LLC55,984$2.14M0.0%+101.8%0.063% 2/18/2026 Elmind Capital LP110,000$4.20M1.2%N/A0.123% 2/18/2026 Engineers Gate Manager LP136,608$5.22M0.1%+244.2%0.153% 2/18/2026 Eversept Partners LP1,174,968$44.90M2.3%-17.1%1.313% 2/18/2026 Cinctive Capital Management LP10,849$415K0.0%-88.5%0.012% 2/18/2026 Artia Global Partners LP70,700$2.70M0.4%+128.8%0.079% 2/18/2026 Apis Capital Advisors LLC186,002$7.11M1.2%+12.0%0.208% 2/18/2026 Armistice Capital LLC3,763,891$143.82M1.7%-44.0%4.207% 2/18/2026 ACT Capital Management LLC3,000$115K0.1%N/A0.003% 2/17/2026 Guggenheim Capital LLC37,203$1.42M0.0%+299.9%0.042% 2/17/2026 PDT Partners LLC148,721$5.68M0.4%-47.2%0.166% 2/17/2026 AQR Capital Management LLC352,717$13.48M0.0%+12.6%0.394% 2/17/2026 Cetera Investment Advisers9,665$369K0.0%N/A0.011% 2/17/2026 Lazard Asset Management LLC9,984$381K0.0%N/A0.011% 2/17/2026 Quantedge Capital Pte Ltd6,600$252K0.1%N/A0.007% 2/17/2026 Jump Financial LLC46,632$1.78M0.0%-85.2%0.052% 2/17/2026 Price T Rowe Associates Inc. MD394,844$15.09M0.0%+397.0%0.441% 2/17/2026 Rock Springs Capital Management LP2,210,322$84.46M4.3%+2.1%2.470% 2/17/2026 Osaic Holdings Inc.7,879$301K0.0%+6,411.6%0.009% 2/17/2026 Adage Capital Partners GP L.L.C.2,927,000$111.84M0.2%-17.6%3.271% 2/17/2026 California State Teachers Retirement System79,472$3.04M0.0%-0.6%0.089% 2/17/2026 Russell Investments Group Ltd.285,311$10.90M0.0%+28.4%0.319% 2/17/2026 State of Wisconsin Investment Board58,926$2.25M0.0%-34.1%0.066% 2/17/2026 Captrust Financial Advisors20,703$791K0.0%+9.3%0.023% 2/17/2026 Fred Alger Management LLC94,832$3.62M0.0%-22.3%0.106% 2/17/2026 Rice Hall James & Associates LLC91,536$3.50M0.2%+8.8%0.102% 2/16/2026 Squarepoint Ops LLC319,658$12.21M0.0%+179.2%0.357% 2/16/2026 Verition Fund Management LLC56,010$2.14M0.0%N/A0.063% 2/16/2026 Panagora Asset Management Inc.587,354$22.44M0.1%+3.1%0.656% 2/16/2026 Mariner LLC18,219$696K0.0%+105.6%0.020% 2/16/2026 Frazier Life Sciences Management L.P.241,592$9.23M0.2%-38.4%0.270% 2/16/2026 Entropy Technologies LP22,201$848K0.0%+32.2%0.025% 2/16/2026 Aigen Investment Management LP11,183$427K0.1%N/A0.012% 2/13/2026 FORA Capital LLC8,023$307K0.0%N/A0.009% 2/13/2026 Marshall Wace LLP217,171$8.30M0.0%-63.2%0.243% 2/13/2026 The Manufacturers Life Insurance Company 39,696$1.52M0.0%-11.1%0.044% 2/13/2026 CANADA LIFE ASSURANCE Co9,779$374K0.0%-58.1%0.011% 2/13/2026 Segall Bryant & Hamill LLC27,187$1.04M0.0%N/A0.030% 2/13/2026 Stifel Financial Corp12,760$488K0.0%N/A0.014% Your book is inside (Ad)The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.Download your copy now.2/13/2026 Smartleaf Asset Management LLC1,193$45K0.0%+69.0%0.001% 2/13/2026 Jacobs Levy Equity Management Inc.268,926$10.28M0.0%-15.5%0.301% 2/13/2026 Essex Investment Management Co. LLC158,709$6.06M0.9%-2.0%0.177% 2/13/2026 Rafferty Asset Management LLC169,208$6.47M0.0%+87.5%0.189% 2/13/2026 First Trust Advisors LP341,724$13.06M0.0%+98.2%0.382% 2/13/2026 OpenArc Corporate Advisory LLC31,000$1.19M0.0%N/A0.035% 2/13/2026 Charles Schwab Investment Management Inc.808,189$30.88M0.0%-4.7%0.903% 2/13/2026 Police & Firemen s Retirement System of New Jersey22,298$852K0.0%-8.5%0.025% 2/13/2026 State Street Corp4,756,666$181.75M0.0%+47.8%5.316% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC215,951$8.25M0.0%+48.0%0.241% TVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TVTX shares? During the previous two years, 262 institutional investors and hedge funds held shares of Travere Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($401.72M), Vanguard Group Inc. ($241.08M), State Street Corp ($181.75M), Perceptive Advisors LLC ($163.47M), Armistice Capital LLC ($143.82M), Adage Capital Partners GP L.L.C. ($111.84M), and Geode Capital Management LLC ($81.92M).Learn more on Travere Therapeutics' institutional investors. Which institutional investors have been buying Travere Therapeutics' stock? Of the 233 institutional investors that purchased Travere Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Assenagon Asset Management S.A. ($3.01M), Driehaus Capital Management LLC ($2.45M), Adage Capital Partners GP L.L.C. ($2.41M), Stephens Investment Management Group LLC ($1.80M), BNP Paribas Financial Markets ($1.73M), State Street Corp ($1.54M), and Armistice Capital LLC ($1.52M). How much institutional buying is happening at Travere Therapeutics? Institutional investors have bought a total of 22,266,369 shares in the last 24 months. This purchase volume represents approximately $560.91M in transactions. Which of Travere Therapeutics' major shareholders have been selling company stock? Of the 103 institutional investors that sold Travere Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Affinity Asset Advisors LLC ($7M), Janus Henderson Group PLC ($6.44M), Armistice Capital LLC ($5.11M), Assenagon Asset Management S.A. ($1.42M), Russell Investments Group Ltd. ($1.06M), Jennison Associates LLC ($908.62K), and Eversept Partners LP ($874.59K). How much institutional selling is happening at Travere Therapeutics? Institutional investors have sold a total of 35,489,920 shares in the last 24 months. This volume of shares sold represents approximately $1.11B in transactions. Related Companies Ascendis Pharma A/S Institutional Ownership Regencell Bioscience Institutional Ownership BridgeBio Pharma Institutional Ownership Summit Therapeutics Institutional Ownership Axsome Therapeutics Institutional Ownership Dr. Reddy's Laboratories Institutional Ownership Arrowhead Pharmaceuticals Institutional Ownership Elanco Animal Health Institutional Ownership Cytokinetics Institutional Ownership Abivax Institutional Ownership This page (NASDAQ:TVTX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
